Delivra Health Brands Income Statement

Financials in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	13.09	13.37	12.38	9.79	8.14	7.96
Revenue Growth (YoY)	4.14%	8.01%	26.42%	20.30%	2.30%	2.24%
Cost of Revenue	6.73	6.59	5.98	4.97	5.54	6.04
Gross Profit	6.36	6.78	6.4	4.82	2.6	1.92
Selling, General & Admin	5.76	6.07	5.77	4.7	6.15	8.31
Research & Development	-	-	-	-	-	0.07
Operating Expenses	6.62	7.62	7.11	6.19	8.62	11.18
Operating Income	-0.26	-0.84	-0.71	-1.36	-6.01	-9.26
Interest Expense	-0.1	-0.12	-0.17	-0.25	-0.64	-
Interest & Investment Income	-	-	-	-	-	0.04
Currency Exchange Gain (Loss)	-0.12	-0.12	-0.07	-0.05	0.01	0
EBT Excluding Unusual Items	-0.48	-1.08	-0.94	-1.67	-6.64	-9.22
Gain (Loss) on Sale of Investments	-	-	-	-0.02	0.49	-0.6
Gain (Loss) on Sale of Assets	-	-	-0.04	0.6	-0.69	-0.24
Asset Writedown	-	-	-	-	-0.4	-12.11
Other Unusual Items	0.07	-0.11	1.86	0.9	0.23	-0.5
Pretax Income	-0.4	-1.19	0.88	-0.18	-7.01	-22.67
Earnings From Continuing Operations	-0.4	-1.19	0.88	-0.18	-7.01	-22.67
Earnings From Discontinued Operations	-	-	-	-	-	-5.87
Net Income to Company	-0.4	-1.19	0.88	-0.18	-7.01	-28.54
Net Income	-0.4	-1.19	0.88	-0.18	-7.01	-28.54
Net Income to Common	-0.4	-1.19	0.88	-0.18	-7.01	-28.54
Shares Outstanding (Basic)	31	31	29	25	25	23
Shares Outstanding (Diluted)	31	31	29	25	25	23
Shares Change (YoY)	0.02%	9.44%	13.08%	-	11.80%	5.06%
EPS (Basic)	-0.01	-0.04	0.03	-0.01	-0.28	-1.26
EPS (Diluted)	-0.01	-0.04	0.03	-0.01	-0.28	-1.26
Free Cash Flow	-0.11	-0.75	0.76	-1.09	-4.45	-9.68
Free Cash Flow Per Share	-0.00	-0.02	0.03	-0.04	-0.18	-0.43
Gross Margin	48.58%	50.70%	51.70%	49.26%	31.99%	24.12%
Operating Margin	-1.99%	-6.29%	-5.74%	-13.92%	-73.87%	-116.39%
Profit Margin	-3.09%	-8.90%	7.08%	-1.88%	-86.12%	-358.70%
Free Cash Flow Margin	-0.85%	-5.64%	6.11%	-11.11%	-54.69%	-121.67%
EBITDA	0.38	0.43	0.6	-0.03	-3.94	-7.04
EBITDA Margin	2.92%	3.19%	4.84%	-0.34%	-48.42%	-88.54%
D&A For EBITDA	0.64	1.27	1.31	1.33	2.07	2.22
EBIT	-0.26	-0.84	-0.71	-1.36	-6.01	-9.26
EBIT Margin	-1.99%	-6.29%	-5.74%	-13.92%	-73.87%	-116.39%
Revenue as Reported	-	-	-	9.79	8.14	7.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.